Viewing Study NCT02096718


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-03-03 @ 12:16 AM
Study NCT ID: NCT02096718
Status: COMPLETED
Last Update Posted: 2016-01-14
First Post: 2014-03-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Afatinib in Subjects With Kidney Dysfunction
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1200.216
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators